LAGE-1 Antibodies

Santa Cruz Biotechnology provides a broad selection of LAGE-1 monoclonal antibodies for research focused on understanding LAGE-1's role in various biological processes. LAGE-1 monoclonal antibodies are validated for multiple applications including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). LAGE-1, or cancer/testis antigen 1, is primarily expressed in testicular germ cells and various tumors, making it a significant marker in cancer research. LAGE-1 expression is associated with tumor progression and immune evasion, highlighting its potential as a target for immunotherapy. Understanding LAGE-1 function can provide insights into tumor biology and the development of novel therapeutic strategies. Researchers can utilize LAGE-1 monoclonal antibodies to explore expression patterns in different tissue types and cellular compartments. LAGE-1 monoclonal antibodies enable detailed investigation of protein-protein interactions and signaling pathways. LAGE-1 monoclonal antibodies support precise detection and quantification in various experimental setups. Santa Cruz Biotechnology monoclonal antibodies for LAGE-1 help advance cancer research and contribute to developing innovative therapeutic approaches in the scientific community.